Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Boosts Revenue by Out-Licensing Patented Technology to Third-Party Partners
High-margin licensing royalties of 5-10% of gross sales of its patented bioscience technology and process are an attractive valuation builder;…